• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溶血性尿毒症综合征中局灶节段性硬化和玻璃样变的发展

Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome.

作者信息

Caletti M G, Gallo G, Gianantonio C A

机构信息

Nephrology Unit, Hospital Garrahan, University of Buenos Aires, Argentina.

出版信息

Pediatr Nephrol. 1996 Dec;10(6):687-92. doi: 10.1007/s004670050189.

DOI:10.1007/s004670050189
PMID:8971879
Abstract

Renal biopsies from 19 boys and 11 girls, most with moderate or severe forms of hemolytic uremic syndrome (HUS) of the classic diarrhea-associated type, were analyzed as part of their long-term follow-up. Patients were biopsied because of late or persistent proteinuria, hypertension, and prolonged renal failure. The median length of follow-up was 11.2 years (range 0.9-22.0 years). Four histological groups were identified: focal segmental glomerulosclerosis and hyalinosis (FSGSH) (17 patients), diffuse mesangial proliferative glomerulonephritis (DMPGN) (9 patients), diffuse glomerulosclerosis (2 patients), and minimal glomerular changes (2 patients). The median interval between the onset of disease and renal biopsy was significantly shorter in DMPGN than in FSGSH (P < 0.001). The pathological findings may be the expression of two different stages of the same dynamic process: a regular sequence of glomerular lesions consisting of early DMPGN, followed by FSGSH. This lesion would ultimately lead to the final stage of global glomerulosclerosis. At the last examination, only a quarter of the patients had normal renal function. These observations also confirm that prolonged oligoanuria during the acute stage of HUS frequently results in an unfavorable long-term prognosis.

摘要

对19名男孩和11名女孩的肾活检组织进行了分析,这些患儿大多患有典型腹泻相关性溶血尿毒综合征(HUS)的中度或重度形式,这是他们长期随访的一部分。患者因晚期或持续性蛋白尿、高血压和长期肾衰竭而接受活检。随访的中位时长为11.2年(范围0.9 - 22.0年)。确定了四个组织学组:局灶节段性肾小球硬化和玻璃样变性(FSGSH)(17例患者)、弥漫性系膜增生性肾小球肾炎(DMPGN)(9例患者)、弥漫性肾小球硬化(2例患者)和轻微肾小球病变(2例患者)。DMPGN组疾病发作至肾活检的中位间隔时间显著短于FSGSH组(P < 0.001)。病理结果可能是同一动态过程两个不同阶段的表现:肾小球病变的规律序列,由早期DMPGN开始,随后是FSGSH。这种病变最终会导致全球肾小球硬化的最终阶段。在最后一次检查时,只有四分之一的患者肾功能正常。这些观察结果也证实,HUS急性期的长期少尿常导致不良的长期预后。

相似文献

1
Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome.溶血性尿毒症综合征中局灶节段性硬化和玻璃样变的发展
Pediatr Nephrol. 1996 Dec;10(6):687-92. doi: 10.1007/s004670050189.
2
The late histologic findings in diarrhea-associated hemolytic uremic syndrome.腹泻相关性溶血尿毒综合征的晚期组织学表现。
J Pediatr. 1998 Aug;133(2):220-3. doi: 10.1016/s0022-3476(98)70223-9.
3
[Hemolytic uremic syndrome. Treatment of secondary glomerulopathy].[溶血性尿毒症综合征。继发性肾小球病的治疗]
Medicina (B Aires). 2005;65(6):528-32.
4
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.腹泻相关性溶血尿毒综合征的长期肾脏预后:一项系统评价、荟萃分析和元回归分析
JAMA. 2003 Sep 10;290(10):1360-70. doi: 10.1001/jama.290.10.1360.
5
Focal segmental sclerosis or scarred focal proliferative glomerulonephritis?局灶节段性硬化还是瘢痕性局灶增生性肾小球肾炎?
Clin Nephrol. 1978 Jun;9(6):229-35.
6
[Glomerulocystic kidney in advanced hemolytic-uremic syndrome].
Pathologica. 2000 Apr;92(2):131.
7
Hemolytic uremic syndrome and crescentic glomerulonephritis complicating childhood nephrosis.溶血尿毒综合征和新月体性肾小球肾炎并发儿童肾病
Clin Nephrol. 1983 Feb;19(2):99-106.
8
Hemolytic uremic syndrome associated with Denys-Drash syndrome.
Pediatr Nephrol. 2000 Oct;14(12):1092-7. doi: 10.1007/s004670000389.
9
Focal segmental glomerular sclerosis: the cellular lesion.
Kidney Int. 1985 Dec;28(6):968-74. doi: 10.1038/ki.1985.225.
10
Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.肾小球顶端病变:微小病变病/局灶节段性肾小球硬化谱系中的一种独特实体。
Kidney Int. 2004 May;65(5):1690-702. doi: 10.1111/j.1523-1755.2004.00563.x.

引用本文的文献

1
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.志贺毒素相关性溶血尿毒综合征:成人患者的特点及对重症监护管理的影响。
Toxins (Basel). 2021 Apr 26;13(5):306. doi: 10.3390/toxins13050306.
2
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.志贺毒素相关性溶血尿毒综合征:一篇叙述性综述。
Toxins (Basel). 2020 Jan 21;12(2):67. doi: 10.3390/toxins12020067.
3
Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea.
用于血栓性微血管病的补体C5抑制疗法:证据不断积累,但并非万灵药。
Clin Kidney J. 2017 Oct;10(5):600-624. doi: 10.1093/ckj/sfx081. Epub 2017 May 8.
4
Thrombotic Microangiopathy in Inverted Formin 2Mediated Renal Disease.倒转成纤维蛋白2介导的肾脏疾病中的血栓性微血管病
J Am Soc Nephrol. 2017 Apr;28(4):1084-1091. doi: 10.1681/ASN.2015101189. Epub 2016 Dec 14.
5
Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.血小板输注对腹泻后溶血尿毒综合征患儿的影响。
Pediatr Nephrol. 2013 Jun;28(6):919-25. doi: 10.1007/s00467-013-2414-y. Epub 2013 Feb 6.
6
Long-term outcomes of Shiga toxin hemolytic uremic syndrome.志贺毒素溶血尿毒综合征的长期预后。
Pediatr Nephrol. 2013 Nov;28(11):2097-105. doi: 10.1007/s00467-012-2383-6. Epub 2013 Jan 4.
7
Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.依那普利和氯沙坦对儿童溶血尿毒综合征的加用降蛋白尿作用。
Pediatr Nephrol. 2013 May;28(5):745-50. doi: 10.1007/s00467-012-2374-7. Epub 2012 Dec 20.
8
Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children.入院时脱水会增加溶血尿毒综合征患儿需要透析的可能性。
Pediatr Nephrol. 2012 Aug;27(8):1407-10. doi: 10.1007/s00467-012-2158-0. Epub 2012 Apr 3.
9
Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.腹泻后溶血尿毒综合征肾病中饮食、依那普利、或氯沙坦的疗效。
Pediatr Nephrol. 2011 Aug;26(8):1247-54. doi: 10.1007/s00467-011-1867-0. Epub 2011 Apr 30.
10
Levels of urinary transforming growth factor beta-1 in children with D+ hemolytic uremic syndrome.儿童 D+ 型溶血尿毒综合征患者尿液中转化生长因子-β1 的水平。
Pediatr Nephrol. 2010 Jun;25(6):1177-80. doi: 10.1007/s00467-009-1434-0. Epub 2010 Feb 16.